Seven out of 10 chronic pain sufferers say they encounter stigma or negative attitudes due to their condition, a new survey says.

The 2019 National Pain Survey, released by Chronic Pain Australia, also reveals patients would like better access to medicinal cannabis and are frustrated by red tape.

More than a third of chronic pain sufferers have spoken to their GP about accessing medicinal cannabis, but say that the responses they have received have not been positive.

“Dismissed and rejected by multiple doctors and pain specialists, who unfortunately are not only ignorant of the growing evidence base for medicinal cannabis but are not even open minded enough to consider the evidence,” said one respondent.

It was also revealed that a whopping 85 percent of respondents said that utilising health professionals for chronic pain management found it unaffordable to do so.

One of the biggest suggestions for what the government could do to support people living with chronic pain was to make medicinal cannabis available on the pharmaceutical benefits scheme (PBS), or at the very least make it easier to access and more affordable.

Other responses from patients inquiring about medicinal cannabis included a “flat out no”, “prescribed pills instead” and that it was “too expensive, and very few doctors who can write a script for it”.

This content does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.